You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people of any age [ID6400]

  • In development
  • Reference number: GID-TA11509
  • Expected publication date:  24 February 2027
  • Project information
  • Project documents

On this page

  1. Invitation to participate
  2. Notes
  3. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6400
  4. Topic selection

Documents

Documents created during the development process.

Invitation to participate

  • Final scope (PDF 132 KB)

    Published:
    09 March 2026
  • Final stakeholder list (PDF 135 KB)

    Published:
    09 March 2026
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 315 KB)

    Published:
    09 March 2026
  • Equality impact assessment (scoping) (PDF 104 KB)

    Published:
    09 March 2026

Notes

  • Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during early March 2026 when we will write to you about how you can get involved.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6400

  • Draft scope post referral (PDF 165 KB)

    Published:
    10 December 2025
  • Provisional stakeholder list post referral (PDF 144 KB)

    Published:
    05 January 2026

Topic selection

  • Topic selection

Back to top